Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Priovant Therapeutics, Inc.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult subjects (18-75 years old)
Diagnosis of non-infectious uveitis (intermediate uveitis, posterior uveitis, or panuveitis)
Active uveitic disease in at least 1 eye
Weight \> 40 kg with a body mass index ≤ 40 kg/m2
You may not be if
Has confirmed or suspected current diagnosis of infectious uveitis History of or have:
1. Lymphoproliferative disorder
2. active malignancy
3. cancer within 5 years prior to screening (exceptions for basal cell carcinoma, squamous cell carcinoma, ductal carcinoma in situ of the breast, carcinoma in situ of the uterine cervix, or thyroid carcinoma.)
4. thrombosis or cerebrovascular ischemic event disease within the last 12 months
5. a high risk for herpes zoster reactivation
6. active or recent infections
Clareo Health | A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
